Sign In
Buy NWBO
$0.191
-0.0008 (-0.417%)
At Close: Jun 22, 2026
Northwest stock rises 9% as company begins cancer vaccine production at UK facility
02:49pm, Thursday, 17'th Feb 2022 Seeking Alpha
Northwest Biotherapeutics (NWBO) began production of its first dendritic cell cancer vaccine for a compassionate use patient at its production facility in Sawston, U.K
Hot Penny Stocks to Add to Your Watchlist Right Now
04:04pm, Thursday, 27'th Jan 2022
Here are three penny stocks that are climbing right now The post Hot Penny Stocks to Add to Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Looking for Penny Stocks to Buy Now? 3 to Know About as 2021 Ends
05:00pm, Tuesday, 21'st Dec 2021
Check these penny stocks out for your watchlist as 2021 ends The post Looking for Penny Stocks to Buy Now? 3 to Know About as 2021 Ends appeared first on Penny Stocks to Buy, Picks, News and Informati
Northwest Biotherapeutics secures $15M financing on stock purchase rights
04:11pm, Monday, 29'th Nov 2021 Seeking Alpha
Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average of $1.32
02:58pm, Thursday, 25'th Nov 2021 Transcript Daily
Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.32 and traded as low as $0.80. Northwest Biotherapeutics shares last traded at $0.89, with a volume of 3,117,501 shares changing hands. The companys 50-day simple []
Northwest Biotherapeutics (OTCMKTS:NWBO) Shares Pass Below Two Hundred Day Moving Average of $1.34
09:10pm, Wednesday, 17'th Nov 2021 Dakota Financial News
Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO)s stock price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.34 and traded as low as $1.04. Northwest Biotherapeutics shares last traded at $1.05, with a volume of 1,632,626 shares trading hands. The companys fifty day []
Northwest Bio: Nowhere To Go But Up
11:35am, Wednesday, 13'th Oct 2021
This is a recap of DCVax-L's pedigree.
Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist
04:05pm, Thursday, 01'st Jul 2021
Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?
UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO)
09:16am, Wednesday, 12'th May 2021
BETHESDA, Md., May 12, 2021 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today
UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO)
04:15am, Wednesday, 12'th May 2021
BETHESDA, Md., May 12, 2021 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today
Northwest Biotherapeutics Announces Development Completed for Initial Production Capacity of Sawston, UK Facility
09:30am, Tuesday, 16'th Mar 2021
BETHESDA, Md., March 16, 2021 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, tod
Northwest Biotherapeutics: Blinded By The Dazzle Of The Unblinding
10:00am, Sunday, 20'th Dec 2020
NWBO has run an 18-year long trial in GBM, one of the deadliest of cancers. It has been mired in controversies, and it has no cash.
Is Northwest Biotheraputics a Buy Ahead of Its Brain Tumor Vaccine Clinical Data Release?
06:15am, Wednesday, 28'th Oct 2020
In a short period of time, this immunotherapy biotech could either become a multi-bagger or trade near $0.
